Annotated Medicine and Device Lists


Dapsone

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.02. ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.4. Antileprosy medicines No observations
PAHO Strategic Fund Medicine List 2.2. Antileprosy med. No observations
Peru 6.2.3 Anti-Leprosy No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Guyana. Essential Medicines List. 2020-2021 7.03. Antileprosy Medicines No observations
Suriname. NGK-C-011 6.05 Anti-Leprosy drugs No observations
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.4. Antileprosy medicines No observations
PAHO Strategic Fund Medicine List 2.2. Antileprosy med. No observations
Peru 6.2.3 Anti-Leprosy No observations
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antileprotic Others observations:
Retard
Costa Rica. Caja Costarricense de Seguro Social. 2019 02. Antibióticos No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 30 TABLETAS
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.02 ANTILEPROTIC DRUGS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 04. ANTIMICOBACTERIAS (TUBERCULOSIS Y LEPRA) No observations
El Salvador - 2019 ANTIMICOBACTERIANOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.02. ANTIBACTERIANOS No observations
Guyana. Essential Medicines List. 2020-2021 7.03. Antileprosy Medicines No observations
Guyana. Essential Medicines List. 2020-2021 7.09.02.04. Anti-pneumocystosis and antitoxoplasmosis Medicines No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8:38 Anti-leprotic agents No observations
Suriname. NGK-C-011 6.05 Anti-Leprosy drugs No observations
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations
Barbados. Barbados National Drug Formulary (BNDF) 08.16.92 Miscellaneous Antimycobacterials No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.4. Antileprosy medicines No observations
PAHO Strategic Fund Medicine List 2.2. Antileprosy med. Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations

Information Resources: Dapsone

Loading ...
Loading ...
Loading ...
No information available